Literature DB >> 6980183

Inhibition by Fab and Fab'2 monoclonal anti-Ia antibody fragments of T-lymphocyte proliferative responses.

F Lemonnier, P Dubreuil, D Caillol.   

Abstract

We investigated the capacity of anti-Ia monoclonal antibody Fab and Fab'2 fragments to inhibit keyhole limpet haemocyanin (KLH) or concanavalin A (Con A)-induced T-cell proliferations. Both types of fragments of anti-I-Ak and anti-I-E/Ck monoclonal antibodies inhibited these responses. On a protein concentration basis, the inhibitory effects of fragmented antibodies were less pronounced than those of undigested molecules. However, once the differences in antigen-binding capacity were compensated, antibody fragments were as efficient inhibitors as undigested molecules. These results suggest (i) that masking of Ia antigenic determinants is the essential mechanism of anti-Ia antibody-mediated inhibitory effect; (ii) that some KLH-specific proliferating T lymphocytes are I-E/Ck restricted; (iii) that the Ia antigen role is not limited to restriction of cell interactions since the Con A-induced proliferation, a non-H-2 restricted response, is inhibited by anti-Ia Fab fragments.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6980183      PMCID: PMC1555320     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  33 in total

1.  T lymphocyte-enriched murine peritoneal exudate cells. III. Inhibition of antigen-induced T lymphocyte Proliferation with anti-Ia antisera.

Authors:  R H Schwartz; C S David; D H Sachs; W E Paul
Journal:  J Immunol       Date:  1976-08       Impact factor: 5.422

Review 2.  Interaction between antigen-presenting cells and primed T lymphocytes: an assessment of Ir gene expression in the antigen-presenting cell.

Authors:  R H Schwartz; A Yano; W E Paul
Journal:  Immunol Rev       Date:  1978       Impact factor: 12.988

3.  Recombination of a mixture of univalent antibody fragments of different specificity.

Authors:  A NISONOFF; M M RIVERS
Journal:  Arch Biochem Biophys       Date:  1961-05       Impact factor: 4.013

4.  Complementation of H-2-linked Ir genes in the mouse.

Authors:  M E Dorf; B Benacerraf
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

5.  Inhibition of dual Ir gene-controlled T-lymphocyte proliferative response to poly (Glu56Lys35Phe9)n with anti-Ia antisera directed against products of either I-A or I-C subregion.

Authors:  R H Schwartz; C S David; M E Dorf; B Benacerraf; W E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

6.  Antibody-induced redistribution of HL-A antigens at the cell surface.

Authors:  F M Kourilsky; D Silvestre; C Neauport-Sautes; Y Loosfelt; J Dausset
Journal:  Eur J Immunol       Date:  1972-06       Impact factor: 5.532

7.  Normal distribution, patching and capping of lymphocyte surface immunoglobulin studied by electron microscopy.

Authors:  S de Petris; M C Raff
Journal:  Nat New Biol       Date:  1973-02-28

8.  Requirement for an Ia-bearing accessory cell in Con A-induced T cell proliferation.

Authors:  G B Ahmann; D H Sachs; R J Hodes
Journal:  J Immunol       Date:  1978-11       Impact factor: 5.422

9.  Distinct epitopes of Ik gene products identified by monoclonal antibodies.

Authors:  M Pierres; F M Kourilsky; J P Rebouah; M Dosseto; D Caillol
Journal:  Eur J Immunol       Date:  1980-12       Impact factor: 5.532

10.  Monoclonal antibody against an Ir gene product?

Authors:  E A Lerner; L A Matis; C A Janeway; P P Jones; R H Schwartz; D B Murphy
Journal:  J Exp Med       Date:  1980-10-01       Impact factor: 14.307

View more
  2 in total

1.  Identification on I-Ak molecules of a functional site recognized by proliferating T-lymphocytes.

Authors:  P C Dubreuil; D Z Birnbaum; D H Caillol; F A Lemonnier
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

2.  The role of products of the human HLA-DR locus (Ia molecules) in in vitro M. leprae driven lymphoproliferation.

Authors:  A Haregewoin; T Yemaneberhan; A Belehu
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.